Brief: Nabriva Therapeutics Reports First Quarter 2021 Financial Results
06/05/2021 21:10
May 6 (Reuters) - Nabriva Therapeutics PLC NBRV.O :
* NABRIVA THERAPEUTICS REPORTS FIRST QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATES
* NABRIVA THERAPEUTICS - REVENUES INCREASED BY $1.7 MILLION
FROM
$0.8 MILLION FOR QUARTER ENDED MARCH 31, 2020 TO $2.5 MILLION
FOR QUARTER ENDED MARCH 31, 2021
* NABRIVA THERAPEUTICS PLC - QTRLY LOSS PER SHARE $0.53
Source text for Eikon: ID:nGNX3H91gp
Further company coverage: NBRV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nabriva Therapeutics
See all newsBrief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
Brief: Nabriva Therapeutics Says Received Delisting Determination Letter From Nasdaq
Brief: Nabriva Therapeutics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Nabriva Therapeutics - On Jan 31, Co's Unit Entered Into Letter Agreement With 2 Units Of Merck & Co, About Distribution Agreement, Dated July 15, 2020
Brief: Nabriva Therapeutics Provides Corporate Update